Gambogic Acid
CAS No. 2752-65-0
Gambogic Acid( B-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone )
Catalog No. M17464 CAS No. 2752-65-0
Gambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 148 | In Stock |
|
| 100MG | 219 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGambogic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
-
DescriptionGambogic acid is a xanthonoid that is derived from the brownish or orange resin from Garcinia hanburyi. This natural chemical has shown promising antitumor activity in clinical trials. Gambogic acid inhibits cell proliferation, angiogenesis and metastasis. Gambogic acid is currently in clinical trials in China.
-
In Vitro——
-
In Vivo——
-
SynonymsB-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorBfl-1| Mcl-1| Bcl-2| Bcl-B| Bcl-w
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2752-65-0
-
Formula Weight628.75
-
Molecular FormulaC38H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL 159.05 mM; H2O : < 0.1 mg/mL
-
SMILES[C@]123C4(OC(C2C[C@@H](C=C1C(=O)c1c(O3)c(c2c(c1O)C=CC(O2)(CCC=C(C)C)C)CC=C(C)C)C4=O)(C)C)C/C=C(/C(=O)O)\C
-
Chemical Name(Z)-4-((1S,3aR,5S,11R,14aS)-8-hydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,11-hexahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhai D, et al. Mol Y Ther, 2008, 7(6), 1639-1646.
molnova catalog
related products
-
RGD peptide GRGDNP
RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.
-
GPRP
GPRP (Gly-Pro-Arg-Pro) is a fibrin polymerization inhibitor that inhibits the interaction between fibrinogen and the platelet membrane glycoprotein IIb/IIIa complex (glycoprotein IIb/IIIa receptor).
-
RBC8
RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
Cart
sales@molnova.com